Navigation Links
LSUHSC's England plays key role in developing new ALS treatment guidelines
Date:10/12/2009

New Orleans, LA Dr. John England, Professor and Chairman of Neurology at LSU Health Sciences Center New Orleans, analyzed research findings and was responsible for the quality and accuracy of evidence analysis and the conclusions of the studies resulting in new guidelines for treating Lou Gehrig's disease, or amyotropic lateral sclerosis (ALS). The guidelines will be published in the October 13, 2009 issue of Neurology, the journal of the American Academy of Neurology.

The guidelines recommend the use of the drug riluzole, the only FDA-approved drug for ALS, to slow the progression of the disease. Assisted-breathing devices and the use of a PEG feeding tube may increase longevity and quality of life. Botulin toxin B may be used to treat drooling if oral medications are not effective. And the guidelines recommend screening patients for behavioral or thinking problems because they commonly occur with this disease and may interfere with treatment choices. Early enrollment in a multidisciplinary ALS clinic is advised because access to specialized treatments may also increase survival and quality of life.

"These new guidelines provide specific, evidence-based recommendations for the care of patients with ALS," notes Dr. England. "Although we do not yet have a cure for this disease, these guidelines identify several treatments that can help people with ALS live longer and better lives."

According to the National Institute of Neurological Disorders, ALS is a rapidly progressive, invariably fatal neurological disease that attacks the nerve cells responsible for controlling voluntary muscles. As many as 20,000 Americans have ALS, and an estimated 5,000 people in the United States are diagnosed with the disease each year. ALS is one of the most common neuromuscular diseases worldwide, and people of all races and ethnic backgrounds are affected. ALS most commonly strikes people between 40 and 60 years of age, but younger and older people can also develop the disease. Men are affected more often than women. In 90-95% if the cases, the disease occurs apparently at random with no clearly associated risk factors.


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Related biology news :

1. Films of Mitchell and Kenyon illuminate lefties decline in Victorian England
2. Mystery of infamous New England Dark Day solved by 3 rings
3. Mystery of infamous New England Dark Day solved by tree rings
4. UNH researchers tag first-ever free-swimming leatherback turtles in New England
5. Study: Illegal fishing harming present and future New England groundfish fisheries
6. Data published in the New England Journal of Medicine support use of raxibacumab (ABthrax) for the treatment of inhalation anthrax
7. Speed plays crucial role in breaking proteins H-bonds
8. Small RNA plays parallel roles in bacterial metabolism
9. Moss protein plays role in Alzheimers disease
10. Early parenting plays key role in infants physiological response to stress
11. Protein identified that plays role in blood flow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... March 27, 2017  Catholic Health Services (CHS) ... Systems Society (HIMSS) Analytics for achieving Stage 6 ... sm . In addition, CHS previously earned a ... using an electronic medical record (EMR). ... level of EMR usage in an outpatient setting.  ...
(Date:3/23/2017)... PUNE, India , March 23, 2017 The report ... Equipment, Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by ... growing at a CAGR of 29.63% between 2017 and 2022. ... ... Logo ...
(Date:3/22/2017)... 2017 Optimove , provider of ... such as 1-800-Flowers and AdoreMe, today announced two ... Replenishment. Using Optimove,s machine learning algorithms, these features ... replenishment recommendations to their customers based not just ... customer intent drawn from a complex web of ...
Breaking Biology News(10 mins):
(Date:9/19/2017)... , ... September 19, 2017 , ... ... largest group of funded early-stage tech companies. “Grit” author Angela Duckworth and her ... joining the ic@3401 community is Cooley, an international law firm with decades of ...
(Date:9/19/2017)... ... 2017 , ... The new and improved Oakton® pocket testers, from Cole-Parmer, stand ... with a new cap design that is versatile, functional and leakproof. They are ideal ... test water quality. , The Oakton pocket testers have many user-friendly and functional features. ...
(Date:9/19/2017)... , Sept. 19, 2017 ValGenesis Inc., ... (VLMS) is pleased to announce the strategic partnership with ... provide clients with validation services using the latest technology ... VTI will provide clients with efficient and cost-effective validation ... marketing partner for the ValGenesis VLMS system. ...
(Date:9/19/2017)... ... 2017 , ... Molecular Devices, LLC, a leader in protein ... the CloneSelect™ Single-Cell Printer™ in North America. This novel system utilizes sophisticated ... documentation of monoclonality for use in cell line development. , Clonal cell ...
Breaking Biology Technology: